1,800
Participants
Start Date
October 31, 2024
Primary Completion Date
May 31, 2025
Study Completion Date
June 30, 2030
2 doses of vaccine Quadrivalent Recombinant Human Papillomavirus Vaccine (Hansenulapolymorpha)
Two doses of the experimental vaccine were injected into the deltoid muscle of the upper arm according to the immunization schedule at 0 and 6 months.
3 doses of vaccine Quadrivalent Recombinant Human Papillomavirus Vaccine (Hansenulapolymorpha)
Three doses of the experimental vaccine were injected into the deltoid muscle of the upper arm according to the immunization schedule at 0, 2, and 6 months.
Chengdu Institute of Biological Products Co.,Ltd.
INDUSTRY
National Vaccine and Serum Institute, China
INDUSTRY